Balyasny Asset Management »

Humacyte shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Humacyte (HUMA) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Humacyte

Tip: Access up to 7 years of quarterly data

All positions including Humacyte held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Humacyte by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $17k 22k 0.78
2022-03-31 $122k 17k 7.06

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Amazon Call Option (AMZN)
Apple Call Option (AAPL)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Select Sector Spdr Tr St Str Finl Etf Call Option (XLF)
Meta Platforms Cl A Call Option (META)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Warner Bros Discovery Com Ser A Call Option (WBD)
Space Exploration Techn Corp Class A Com Stk Call Option (SPCX)
Microsoft Corporation Call Option (MSFT)
Tesla Motors Call Option (TSLA)

View all positions for Balyasny Asset Management

Top funds holding Humacyte

Vanguard Capital Management
Antipodes Partners
Alyeska Investment Group
Davidson Kempner Capital Management
BlackRock
Dr. Jeffrey R. Jay, M.D.
State Street Corporation
Susquehanna International
UBS Group
AQR Capital Management
Geode Capital Management
Millennium Management
Citadel Advisors
Charles Schwab Investment Management
Sixth Street Partners Management Company

View all funds holding Humacyte